Dr. Martens (DOCS) Competitors

Dr. Martens logo
GBX 55 -0.20 (-0.36%)
As of 12:28 PM Eastern

DOCS vs. WOSG, COA, MUL, PTD, and NBU

Should you buy Dr. Martens stock or one of its competitors? Dr. Martens's main competitors and comparable companies include Watches of Switzerland Group (WOSG), Coats Group (COA), Mulberry Group (MUL), Pittards (PTD), and Naibu Global International (NBU). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "textiles, apparel & luxury goods" industry.

How does Dr. Martens compare to Watches of Switzerland Group?

Dr. Martens (LON:DOCS) and Watches of Switzerland Group (LON:WOSG) are both small-cap consumer discretionary companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

Dr. Martens has higher earnings, but lower revenue than Watches of Switzerland Group. Watches of Switzerland Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dr. Martens£733.30M0.72£68.97M£2.4022.92
Watches of Switzerland Group£1.83B0.96£60.02M£42.6017.89

In the previous week, Dr. Martens had 10 more articles in the media than Watches of Switzerland Group. MarketBeat recorded 15 mentions for Dr. Martens and 5 mentions for Watches of Switzerland Group. Dr. Martens' average media sentiment score of 0.35 beat Watches of Switzerland Group's score of 0.27 indicating that Dr. Martens is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Dr. Martens
2 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Neutral
Watches of Switzerland Group
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Dr. Martens presently has a consensus price target of GBX 105, suggesting a potential upside of 90.91%. Watches of Switzerland Group has a consensus price target of GBX 696.67, suggesting a potential downside of 8.57%. Given Dr. Martens' stronger consensus rating and higher probable upside, equities analysts plainly believe Dr. Martens is more favorable than Watches of Switzerland Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dr. Martens
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Watches of Switzerland Group
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Watches of Switzerland Group has a net margin of 5.42% compared to Dr. Martens' net margin of 3.79%. Watches of Switzerland Group's return on equity of 16.31% beat Dr. Martens' return on equity.

Company Net Margins Return on Equity Return on Assets
Dr. Martens3.79% 8.05% 8.12%
Watches of Switzerland Group 5.42%16.31%7.41%

43.0% of Dr. Martens shares are owned by institutional investors. Comparatively, 54.2% of Watches of Switzerland Group shares are owned by institutional investors. 3.0% of Dr. Martens shares are owned by company insiders. Comparatively, 4.5% of Watches of Switzerland Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Dr. Martens has a beta of 0.262, suggesting that its share price is 74% less volatile than the broader market. Comparatively, Watches of Switzerland Group has a beta of 1.947, suggesting that its share price is 95% more volatile than the broader market.

Summary

Dr. Martens and Watches of Switzerland Group tied by winning 8 of the 16 factors compared between the two stocks.

How does Dr. Martens compare to Coats Group?

Dr. Martens (LON:DOCS) and Coats Group (LON:COA) are both small-cap consumer discretionary companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Dr. Martens pays an annual dividend of GBX 2.55 per share and has a dividend yield of 4.6%. Coats Group pays an annual dividend of GBX 3.28 per share and has a dividend yield of 4.3%. Dr. Martens pays out 106.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Coats Group pays out 60.9% of its earnings in the form of a dividend.

In the previous week, Dr. Martens had 13 more articles in the media than Coats Group. MarketBeat recorded 15 mentions for Dr. Martens and 2 mentions for Coats Group. Dr. Martens' average media sentiment score of 0.35 beat Coats Group's score of 0.00 indicating that Dr. Martens is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Dr. Martens
2 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Neutral
Coats Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Dr. Martens presently has a consensus target price of GBX 105, suggesting a potential upside of 90.91%. Coats Group has a consensus target price of GBX 120.25, suggesting a potential upside of 57.40%. Given Dr. Martens' higher possible upside, analysts clearly believe Dr. Martens is more favorable than Coats Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dr. Martens
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Coats Group
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

43.0% of Dr. Martens shares are owned by institutional investors. Comparatively, 64.8% of Coats Group shares are owned by institutional investors. 3.0% of Dr. Martens shares are owned by insiders. Comparatively, 3.2% of Coats Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Coats Group has higher revenue and earnings than Dr. Martens. Coats Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dr. Martens£733.30M0.72£68.97M£2.4022.92
Coats Group£1.60B0.92£75.12M£5.3914.17

Dr. Martens has a beta of 0.262, suggesting that its share price is 74% less volatile than the broader market. Comparatively, Coats Group has a beta of 1.258, suggesting that its share price is 26% more volatile than the broader market.

Coats Group has a net margin of 6.60% compared to Dr. Martens' net margin of 3.79%. Coats Group's return on equity of 14.43% beat Dr. Martens' return on equity.

Company Net Margins Return on Equity Return on Assets
Dr. Martens3.79% 8.05% 8.12%
Coats Group 6.60%14.43%8.48%

Summary

Coats Group beats Dr. Martens on 13 of the 18 factors compared between the two stocks.

How does Dr. Martens compare to Mulberry Group?

Mulberry Group (LON:MUL) and Dr. Martens (LON:DOCS) are both small-cap consumer discretionary companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk and institutional ownership.

Dr. Martens has a consensus target price of GBX 105, suggesting a potential upside of 90.91%. Given Dr. Martens' stronger consensus rating and higher possible upside, analysts clearly believe Dr. Martens is more favorable than Mulberry Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mulberry Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Dr. Martens
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Dr. Martens has higher revenue and earnings than Mulberry Group. Mulberry Group is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mulberry Group£125.47M1.53-£39.32M-£13.00N/A
Dr. Martens£733.30M0.72£68.97M£2.4022.92

Mulberry Group has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, Dr. Martens has a beta of 0.262, meaning that its stock price is 74% less volatile than the broader market.

Dr. Martens has a net margin of 3.79% compared to Mulberry Group's net margin of -6.72%. Mulberry Group's return on equity of 78.71% beat Dr. Martens' return on equity.

Company Net Margins Return on Equity Return on Assets
Mulberry Group-6.72% 78.71% -8.70%
Dr. Martens 3.79%8.05%8.12%

In the previous week, Dr. Martens had 14 more articles in the media than Mulberry Group. MarketBeat recorded 15 mentions for Dr. Martens and 1 mentions for Mulberry Group. Mulberry Group's average media sentiment score of 0.57 beat Dr. Martens' score of 0.35 indicating that Mulberry Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mulberry Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Dr. Martens
2 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Neutral

0.5% of Mulberry Group shares are held by institutional investors. Comparatively, 43.0% of Dr. Martens shares are held by institutional investors. 1.4% of Mulberry Group shares are held by insiders. Comparatively, 3.0% of Dr. Martens shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Dr. Martens beats Mulberry Group on 12 of the 16 factors compared between the two stocks.

How does Dr. Martens compare to Pittards?

Dr. Martens (LON:DOCS) and Pittards (LON:PTD) are both small-cap consumer discretionary companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends.

Dr. Martens pays an annual dividend of GBX 2.55 per share and has a dividend yield of 4.6%. Pittards pays an annual dividend of GBX 1 per share. Dr. Martens pays out 106.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Pittards pays out 3,333.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Dr. Martens is clearly the better dividend stock, given its higher yield and lower payout ratio.

Dr. Martens currently has a consensus price target of GBX 105, suggesting a potential upside of 90.91%. Given Dr. Martens' stronger consensus rating and higher possible upside, research analysts clearly believe Dr. Martens is more favorable than Pittards.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dr. Martens
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Pittards
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

43.0% of Dr. Martens shares are held by institutional investors. Comparatively, 30.0% of Pittards shares are held by institutional investors. 3.0% of Dr. Martens shares are held by insiders. Comparatively, 68.6% of Pittards shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Dr. Martens has a net margin of 3.79% compared to Pittards' net margin of 1.97%. Dr. Martens' return on equity of 8.05% beat Pittards' return on equity.

Company Net Margins Return on Equity Return on Assets
Dr. Martens3.79% 8.05% 8.12%
Pittards 1.97%3.08%2.32%

Dr. Martens has a beta of 0.262, suggesting that its share price is 74% less volatile than the broader market. Comparatively, Pittards has a beta of 0.67, suggesting that its share price is 33% less volatile than the broader market.

In the previous week, Dr. Martens had 15 more articles in the media than Pittards. MarketBeat recorded 15 mentions for Dr. Martens and 0 mentions for Pittards. Dr. Martens' average media sentiment score of 0.35 beat Pittards' score of 0.00 indicating that Dr. Martens is being referred to more favorably in the media.

Company Overall Sentiment
Dr. Martens Neutral
Pittards Neutral

Dr. Martens has higher revenue and earnings than Pittards. Pittards is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dr. Martens£733.30M0.72£68.97M£2.4022.92
Pittards£20.37M0.00N/A£0.03N/A

Summary

Dr. Martens beats Pittards on 13 of the 16 factors compared between the two stocks.

How does Dr. Martens compare to Naibu Global International?

Naibu Global International (LON:NBU) and Dr. Martens (LON:DOCS) are both consumer discretionary companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings and profitability.

Dr. Martens has higher revenue and earnings than Naibu Global International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Naibu Global InternationalN/AN/AN/AN/AN/A
Dr. Martens£733.30M0.72£68.97M£2.4022.92

43.0% of Dr. Martens shares are owned by institutional investors. 3.0% of Dr. Martens shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Dr. Martens had 15 more articles in the media than Naibu Global International. MarketBeat recorded 15 mentions for Dr. Martens and 0 mentions for Naibu Global International. Dr. Martens' average media sentiment score of 0.35 beat Naibu Global International's score of 0.00 indicating that Dr. Martens is being referred to more favorably in the news media.

Company Overall Sentiment
Naibu Global International Neutral
Dr. Martens Neutral

Dr. Martens has a consensus target price of GBX 105, indicating a potential upside of 90.91%. Given Dr. Martens' stronger consensus rating and higher probable upside, analysts clearly believe Dr. Martens is more favorable than Naibu Global International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Naibu Global International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Dr. Martens
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Dr. Martens has a net margin of 3.79% compared to Naibu Global International's net margin of 0.00%. Dr. Martens' return on equity of 8.05% beat Naibu Global International's return on equity.

Company Net Margins Return on Equity Return on Assets
Naibu Global InternationalN/A N/A N/A
Dr. Martens 3.79%8.05%8.12%

Summary

Dr. Martens beats Naibu Global International on 11 of the 11 factors compared between the two stocks.

Get Dr. Martens News Delivered to You Automatically

Sign up to receive the latest news and ratings for DOCS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DOCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DOCS vs. The Competition

MetricDr. MartensTextiles, Apparel & Luxury Goods IndustryConsumer Discretionary SectorLON Exchange
Market Cap£526.50M£10.06B£12.82B£2.75B
Dividend Yield4.83%2.62%3.12%5.11%
P/E Ratio22.9231.6125.9323.13
Price / Sales0.721.361.734.99
Price / Cash14.2916.2515.2820.23
Price / Book1.454.523.522.47
Net Income£68.97M£462.87M£445.49M£5.88B
7 Day Performance-15.38%-2.93%-2.60%-1.94%
1 Month Performance-20.06%0.75%-2.28%-3.34%
1 Year Performance-33.66%18.39%-1.44%7.20%

Dr. Martens Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DOCS
Dr. Martens
3.6389 of 5 stars
GBX 55
-0.4%
GBX 105
+90.9%
-34.5%£526.50M£733.30M22.92890
WOSG
Watches of Switzerland Group
1.3407 of 5 stars
GBX 795
+5.9%
GBX 696.67
-12.4%
+73.1%£1.84B£1.83B18.662,942
COA
Coats Group
3.7109 of 5 stars
GBX 76.60
-3.3%
GBX 120.25
+57.0%
-5.1%£1.47B£1.60B14.2119,000
MUL
Mulberry Group
N/AGBX 262
+12.4%
N/A+193.4%£183.82M£125.47MN/A1,300
PTD
Pittards
N/AN/AN/AN/A£772K£20.37M179.171,095

Related Companies and Tools


This page (LON:DOCS) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners